Fludarabin Actavis 25 mg/ ml Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

fludarabin actavis 25 mg/ ml

actavis group ptc ehf - fludarabinfosfat - konsentrat til injeksjons-/infusjonsvæske, oppløsning - 25 mg/ ml

Irbesartan Actavis 150 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

irbesartan actavis 150 mg

actavis group ptc ehf - irbesartan - tablett, filmdrasjert - 150 mg

Irbesartan Actavis 300 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

irbesartan actavis 300 mg

actavis group ptc ehf - irbesartan - tablett, filmdrasjert - 300 mg

Nemdatine Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

nemdatine

actavis group ptc ehf. - memantin - alzheimers sykdom - psychoanaleptics, , andre anti-demens legemidler - behandling av pasienter med moderat til alvorlig alzheimers sykdom.

Pinex 250 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

pinex 250 mg

actavis group ptc ehf - paracetamol - granulat i dosepose med jordbærsmak - 250 mg

Potactasol Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

potactasol

actavis group ptc ehf - topotekan - uterine cervical neoplasms; small cell lung carcinoma - antineoplastiske midler - topotecan monotherapy is indicated for the treatment of:- patients with metastatic carcinoma of the ovary after failure of first-line or subsequent therapy- patients with relapsed small cell lung cancer (sclc) for whom re-treatment with the first-line regimen is not considered appropriate (see section 5. topotecan i kombinasjon med cisplatin er indisert for pasienter med karsinom i cervix tilbakevendende etter strålebehandling, og for pasienter med stadium ivb sykdom. patients with prior exposure to cisplatin require a sustained treatment free interval to justify treatment with the combination (see section 5.

Rapilysin Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

rapilysin

actavis group ptc ehf - reteplase - hjerteinfarkt - antithrombotic agents - rapilysin is indicated for the thrombolytic treatment of suspected myocardial infarction with persistent st elevation or recent left bundle branch block within 12 hours after the onset of acute-myocardial-infarction (ami) symptoms.

Abrysvo Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

abrysvo

pfizer europe ma eeig - respiratory syncytial virus, subgroup a, stabilized prefusion f protein / respiratory syncytial virus, subgroup b, stabilized prefusion f protein - respiratorisk syncytialvirusinfeksjoner - vaksiner - abrysvo is indicated for:passive protection against lower respiratory tract disease caused by respiratory syncytial virus (rsv) in infants from birth through 6 months of age following maternal immunisation during pregnancy. se avsnitt 4. 2 og 5. active immunisation of individuals 60 years of age and older for the prevention of lower respiratory tract disease caused by rsv. bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.

Alisade Եվրոպական Միություն - Նորվեգերեն - EMA (European Medicines Agency)

alisade

glaxo group ltd. - flutikasonfuroat - rhinitis, allergic, perennial; rhinitis, allergic, seasonal - nasale preparater - voksne, ungdom (12 år og eldre) og barn (6-11 år). alisade er indisert for behandling av symptomene på allergisk rhinitt.

Ciprofloxacin Actavis 500 mg Նորվեգիա - Նորվեգերեն - Statens legemiddelverk

ciprofloxacin actavis 500 mg

actavis group ptc ehf - ciprofloksacinhydroklorid - tablett, filmdrasjert - 500 mg